Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.
Airways
Alveolar hemorrhage
Antiphospholipid syndrome
Interstitial lung disease
Pleuritis
Pulmonary embolism
Pulmonary hypertension
Systemic lupus erythematosus
Journal
Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
entrez:
5
8
2019
pubmed:
5
8
2019
medline:
31
3
2020
Statut:
ppublish
Résumé
Systemic lupus erythematosus (SLE) is a systemic inflammatory disease, characterized by an antibody response to nucleic antigens and involvement of any organ system. Pulmonary manifestations are frequent and include pleuritis, acute lupus pneumonitis, chronic interstitial lung disease, alveolar hemorrhage, shrinking lung syndrome, airway disease, pulmonary hypertension (PH), and thromboembolic disease. The antiphospholipid antibody syndrome (APLAS) is a systemic autoimmune disorder where different prothrombotic factors interact to induce arterial and venous thrombosis. The most common pulmonary manifestations are pulmonary thromboembolism and PH. This review will focus on the clinical presentation, diagnosis, and management of the SLE- and APLAS-associated pulmonary conditions.
Identifiants
pubmed: 31376888
pii: S0272-5231(19)30042-5
doi: 10.1016/j.ccm.2019.06.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
519-529Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.